a2 National Symposium

Deepak Ganesan, PhD, is a professor and Manning Fellow in the Department of Computer Science at UMass Amherst, and co-principal investigator for MassAITC. He also served as director of the Center for Personalized Health Monitoring (CPHM) at UMass Amherst from 2019–2024 and led its efforts toward end-to-end design of new health sensors from prototyping and fabrication to mobile health (mHealth) applications. He also served as the sensors-to-information thrust lead for the Mobile Data to Knowledge (MD2K) center funded by the National Institutes of Health.

Dr. Ganesan received his PhD in computer science from UCLA in 2004. He received the NSF CAREER Award in 2006, the IBM Faculty Award in 2008, and the UC3M-Santander Chair of Excellence in 2019. He was selected as a UMass Junior Faculty Fellow in 2008, and a UMass Lilly Teaching Fellow in 2009. He has served as program co-chair for ACM Mobicom 2024, MobiSys 2017, ACM SenSys 2010, and IEEE SECON 2013. His work has been recognized by ACM SIGMOBILE and ACM Research Highlights, a Test of Time Award at SenSys 2022, and best paper nominations or awards at various top conferences in computer science including ACM MobiSys, Mobicom, CHI, Ubicomp and IEEE SECON. He is an ACM Fellow.

Vadim Gladyshev, PhD, is a professor of medicine at Harvard Medical School and director of the Center for Redox Medicine at Brigham and Women’s Hospital. Dr. Gladyshev’s lab focuses on studying aging, rejuvenation, and lifespan control using a combination of experimental and computational approaches. He has published more than 400 articles. Dr. Gladyshev is the recipient of NIH Pioneer, Transformative, and Eureka awards and is an elected member of the National Academy of Sciences.

‍

David J. Glass, MD, is a vice president of research at Regeneron Pharmaceuticals, overseeing a group focused on aging and age-associated disorders. He’s also the director of Regeneron’s postdoctoral fellowship program. Dr. Glass teaches courses on experimental design, and on the history and philosophy of experimentation in biology; these courses are given via his senior lecturer position in the Department of Cell Biology at Harvard Medical School, and as an adjunct professor in the Department of Genetics and Development at Columbia University’s Vagelos College of Physicians and Surgeons.

Dr. Glass holds a BS from Columbia University and an MD from New York Medical College, and conducted postdoctoral work at Columbia. He is an elected fellow of the American Association for the Advancement of Science (AAAS) and the American Society for Clinical Investigation (ASCI), and an elected member of the National Academy of Sciences. He is the co-author of more than 140 peer-reviewed research articles on cell signaling mechanisms in neuromuscular junction formation, skeletal muscle atrophy and hypertrophy, obesity, and mechanisms associated with aging. He is the author of Experimental Design for Biologists, published by Cold Spring Harbor Press, which is now in its second edition.

‍

Todd Haim, PhD, serves as senior advisor on biomedical innovation at the National Institute on Aging (NIA) and directs the NIA Office of Strategic Extramural Programs. He oversees approximately $150 million in annual seed funding that supports startups advancing cutting-edge technologies in aging, including AI-driven tools, digital health solutions, and next-generation biomedical innovations. Dr. Haim leads a team dedicated to strengthening NIA’s training, career development, and small business programs, expanding resources that help innovators translate scientific discoveries into real-world impact.

Before joining NIA, Dr. Haim served as program director at the National Cancer Institute’s SBIR Development Center and held roles at the National Academy of Sciences and Pfizer. He earned his PhD in biomedical research from the Albert Einstein College of Medicine and a technology commercialization certificate from the Johns Hopkins Carey Business School. Dr. Haim’s work has been recognized nationally through multiple awards, including the 2024 Champion of Small Business Commercialization Award and several NIH Director’s Awards.

‍

Amelia Hay, MBA, serves as VP of startup programming and investments at AgeTech Collaborative™ from AARP, where she leads various initiatives supporting the ecosystem, including sourcing startups, organizing pitch events, and executing the startup accelerator program. Additionally, she oversees all event and conference execution for the AgeTech Collaborative and manages startup investments. Prior to this role, Hay spent over 20 years specializing in financial planning and analysis at MCI, Verizon, and AARP, focusing on business modeling and case building for new products and multi-year projects.

‍

Ken Honeycutt is the director of Samsung Health at Samsung Electronics, where he leads the development and implementation of innovative digital health solutions to enhance the quality and accessibility of healthcare for millions of users.

Before joining Samsung Health, Honeycutt held roles in innovation and strategy for some of the largest healthcare vendors and providers in the United States, including Cardinal Health, McKesson, Cerner, the University of Pittsburgh Medical Center (UPMC), and IBM. He has also contributed to multiple patents and publications in the field of healthcare technology.

‍

Winn Hong, MBA, MS, is the North America venture manager at Nokia Ventures and the co-founder, president, and CEO of Mesencyte Inc. With over 18 years of experience in high-tech innovation, entrepreneurship, and leadership, he has successfully guided ventures across biotechnology, medical devices, alternative fuel, and digital technology. A fellow of the American Institute for Medical and Biological Engineering, he has held key roles including deputy executive director at the Alfred E. Mann Institute for Biomedical Engineering at the University of Southern California and senior technology strategist at UCLA’s Institute for Technology Advancement.

Earlier in his career, Hong worked at NASA’s Jet Propulsion Laboratory, contributing to the design and testing of advanced sensors for military, medical, and space applications. He later served as COO of Sega.com Inc. and Sega.com Ltd. (publicly traded on the Hong Kong Stock Exchange) and principal at Convergent Ventures, managing early-stage investments in life sciences and technology. He holds an MBA from the University of Chicago as well as an MS in mechanical engineering and a BS in aerospace engineering, both from UCLA.

Michael Hughes, MBA, is the vice president of strategic growth and partnership for LeadingAge National, a Washington, D.C.–based trade association representing over 5,000 nonprofit senior living communities and aging service providers. In this role, he works to identify and define new growth strategies for LeadingAge members with a focus on health and wellness.  

Hughes previously served as the chief transformation and innovation officer for United Church Homes, with additional leadership experience in the home care space and at AARP. He holds an MBA from McGill University.

‍

Anand Iyer, PhD, MBA, is the chief AI officer at Welldoc. Technology's highest purpose in healthcare is to elevate the human experience. This mission is deeply personal to Dr. Iyer, who lives with type 2 diabetes. At Welldoc, he leads the company’s AI and data intelligence strategy, crafting the next generation of health tech with more predictive, adaptive, and personal capabilities. He ensures Welldoc’s innovation is scientifically rigorous, ethical, and focused on empowering individual health journeys.

An innovator and respected global thought leader, Dr. Iyer pioneered BlueStar®, the first FDA-cleared digital therapeutic. Always on a quest to learn, he regularly connects with industry leaders across healthcare, tech, and academia. His proven ability to evolve and pivot is the ultimate proof that curiosity never stands still and is the engine for rethinking healthcare.

Soo Jeon, MPP, is a healthcare innovation leader and venture executive who leads Healthworx Accelerator. At Healthworx, the innovation and investment arm of CareFirst BlueCross BlueShield, she focuses on identifying, investing in, and scaling emerging healthcare technologies and care models that improve outcomes, affordability, and member experience—particularly in areas such as digital health, data-driven care, and new delivery models. Jeon brings a multidisciplinary background spanning strategy, venture investing, and partnerships across the healthcare ecosystem, working closely with startups, providers, payers, and policymakers to accelerate adoption of high-impact solutions. Her work centers on translating innovation into real-world implementation within large health systems, helping bridge the gap between early-stage companies and sustainable, system-level change. Prior to joining Healthworx, Jeon was a senior associate with the Aspen Global Leadership Network at the Aspen Institute.

Jason Karlawish, MD, is a professor of medicine, medical ethics and health policy, and neurology at the University of Pennsylvania, where he also serves as co-director of the Penn Memory Center and co-principal investigator and Clinical Translation and Validation Core co-lead for PennAITech. Dr. Karlawish is a physician and writer who researches and writes about issues at the intersections of bioethics, aging, and the neurosciences. He is the author of The Problem of Alzheimer’s: How Science, Culture, and Politics Turned a Rare Disease into a Crisis and What We Can Do About It and the novel Open Wound: The Tragic Obsession of Dr. William Beaumont. His essays have been published in The Wall Street Journal, The New York Times, Forbes, The Hill, The Los Angeles Times, The Philadelphia Inquirer, STAT, and The Washington Post. He is the producer of The Age of Aging, a podcast that examines how to live well with an aging brain.

Dr. Karlawish serves on the Pennsylvania Advisory Council on Elder Justice in the Courts; AARP’s Global Council on Brain Health; the Board of Directors for The Greenwall Foundation, a grant making foundation dedicated to expanding bioethics knowledge to improve clinical, biomedical, and public health decision-making, policy, and practice; and for Play On! Philly, a nonprofit providing orchestral music education for underserved children throughout Philadelphia.

‍

‍Thomas Keane, MD, MBA, serves as assistant secretary for technology policy and national coordinator for health information technology. An engineer and physician, Dr. Keane previously served in the Office of the National Coordinator for Health Information Technology and as a senior advisor to the deputy secretary of the U.S. Department of Health and Human Services. Among other duties, he was an administrator of the COVID-19 Provider Relief Fund and led the development of the Agency for Healthcare Research and Quality (AHRQ) National Nursing Home COVID Action Network. Dr. Keane worked as a finite element software developer and enterprise software engineer prior to training as an interventional radiologist.